多巴胺和血清素反向调节D2中等脊髓神经元,以调节可卡因奖励
Daniel F Cardozo Pinto1,2,3, Michaela Y Guo4, Matthew B Pomrenze4
1Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. dcardozopinto@fas.harvard.edu.
Nature communications
|March 15, 2026
概括
血清素 (5HT) 激发D2-MSN,反对多巴胺的 (DA) 作用. 这种对D2-MSN的5HTergic刺激抵消了可卡因的强化作用,揭示了神经调节器作用的关键电路机制.
科学领域:
- 神经科学是一个神经科学.
- 神经药理学神经药理学
- 分子精神病学分子精神病学
背景情况:
- 状多巴胺 (DA) 和血清素 (5-基三胺; 5HT) 具有相反的行为功能.
- 调解这些对抗效应的精确神经回路尚不清楚.
研究的目的:
- 为了研究5HT如何调节条形电路以反对DA的影响.
- 为了确定特定的5HT受体和参与调节奖励行为的神经元群体.
主要方法:
- 在小鼠条体中映射5HT受体表达.
- 来自遗传识别的条状神经元的电生理学记录.
- 在体内评估神经元活动使用cfos表达.
- 在基因改造小鼠中对可卡因敏感性的行为分析.
主要成果:
- 激发性5HT受体富含D2-MSN,它们表达抑制性D2 DA受体.
- 5HT反向调节D2-MSN的激发,而5HT2a和5HT2c受体则调节这种激发.
- 在体内证实了D2-MSNs的5HTergic激发.
- 在D2-MSN中失去5HT2c受体功能增加了对可卡因的敏感性.
结论:
- 状5HT激发D2-MSN,抵消DA的影响.
- 这种通过D2-MSN的5HTergic通路调节了可卡因的回报.
- 确定了DA和5HT在行为中的对立作用的关键电路机制.
相关概念视频
Adrenergic Agonists: Indirect-Acting Agents
2.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.9K
Drugs Affecting Neurotransmitter Release or Uptake
1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
Drugs Affecting Neurotransmitter Synthesis
2.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K
Neurochemical Transmission: Sites of Drug Action
3.8K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.8K
Drug Abuse and Addiction: Pharmacological Phenomena
1.4K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.4K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.1K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K


